|
1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kollarova H, Machova L, Horakova D,
Janoutova G and Janout V: Epidemiology of esophageal cancer - an
overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech
Repub. 151:17–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bohanes P, Yang D, Chhibar RS, Labonte MJ,
Winder T, Ning Y, Gerger A, Benhaim L, Paez D, Wakatsuki T, et al:
Influence of sex on the survival of patients with esophageal
cancer. J Clin Oncol. 30:2265–2272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu J, Xie X, Zhou C, Peng S, Rao D and Fu
J: Which factors are associated with actual 5-year survival of
oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg.
41:e7–e11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nana-Sinkam SP and Croce CM: Clinical
applications for microRNAs in cancer. Clin Pharmacol Ther.
93:98–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yi Y, Lu X, Chen J, Jiao C, Zhong J, Song
Z, Yu X and Lin B: Downregulated miR-486-5p acts as a tumor
suppressor in esophageal squamous cell carcinoma. Exp Ther Med.
12:3411–3416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferracin M, Veronese A and Negrini M:
Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev
Mol Diagn. 10:297–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li
M, Cao RS, Hao B, Zhang HJ, Qiu HQ, et al: MicroRNA-183 promotes
proliferation and invasion in oesophageal squamous cell carcinoma
by targeting programmed cell death 4. Br J Cancer. 111:2003–2013.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis by
targeting protumorigenic ARHGAP5 in lung cancer. Oncogene.
33(1181–1189): 21042014.
|
|
15
|
Zhang G, Liu Z, Cui G, Wang X and Yang Z:
MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in
breast cancer cells. Tumour Biol. 35:11137–11145. 2104. View Article : Google Scholar
|
|
16
|
Huang XP, Hou J, Shen XY, Huang CY, Zhang
XH, Xie YA and Luo XL: MicroRNA-486-5p, which is downregulated in
hepatocellular carcinoma, suppresses tumor growth by targeting
PIK3R1. FEBS J. 282:579–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ferretti E, De Smaele E, Miele E, Laneve
P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E,
Screpanti I, et al: Concerted microRNA control of Hedgehog
signalling in cerebellar neuronal progenitor and tumour cells. EMBO
J. 27:2616–2627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ
and White RW: miR-125b promotes growth of prostate cancer xenograft
tumor through targeting pro-apoptotic genes. Prostate. 71:538–549.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujino Y, Takeishi S, Nishida K, Okamoto
K, Muguruma N, Kimura T, Kitamura S, Miyamoto H, Fujimoto A,
Higashijima J, et al: Downregulation of miR-100/miR-125b is
associated with lymph node metastasis in early colorectal cancer
with submucosal invasion. Cancer Sci. 108:390–397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Y, Liu X, Zhang Q, Mao X, Feng L, Su
P, Chen H, Guo Y and Jin F: Oncogenic potential of TSTA3 in breast
cancer and its regulation by the tumor suppressors miR-125a-5p and
miR-125b. Tumour Biol. 37:4963–4972. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu J, Wang Y and Wu X: MicroRNA in the
pathogenesis and prognosis of esophageal cancer. Curr Pharm Des.
19:1292–1300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakai NS, Samia-Aly E, Barbera M and
Fitzgerald RC: A review of the current understanding and clinical
utility of miRNAs in esophageal cancer. Semin Cancer Biol.
23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mayne GC, Hussey DJ and Watson DI:
MicroRNAs and esophageal cancer - implications for pathogenesis and
therapy. Curr Pharm Des. 19:1211–1226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin YY, Chen QJ, Xu K, Ren HT, Bao X, Ma
YN, Wei Y and Ma HB: Involvement of microRNA-141-3p in
5-fluorouracil and oxaliplatin chemo-resistance in esophageal
cancer cells via regulation of PTEN. Mol Cell Biochem. 422:161–170.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han N, Zhao W, Zhang Z and Zheng P:
MiR-328 suppresses the survival of esophageal cancer cells by
targeting PLCE1. Biochem Biophys Res Commun. 470:175–180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen L, Wang Q, Wang GD, Wang HS, Huang Y,
Liu XM and Cai XH: miR-16 inhibits cell proliferation by targeting
IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS
Lett. 587:1366–1372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q
and Ma B: MicroRNA-34a inhibits the proliferation and metastasis of
osteosarcoma cells both in vitro and in vivo. PLoS One.
7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duan Z, Choy E, Harmon D, Liu X, Susa M,
Mankin H and Hornicek F: MicroRNA-199a-3p is downregulated in human
osteosarcoma and regulates cell proliferation and migration. Mol
Cancer Ther. 10:1337–1345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jianwei Z, Fan L, Xiancheng L, Enzhong B,
Shuai L and Can L: MicroRNA 181a improves proliferation and
invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol.
34:3331–3337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang D, Zhan M, Chen T, Chen W, Zhang Y,
Xu S, Yan J, Huang Q and Wang J: miR-125b-5p enhances chemotherapy
sensitivity to cisplatin by down-regulating Bcl2 in gallbladder
cancer. Sci Rep. 7:431092017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu X, Shi W, Zhang Y, Wang X, Sun S, Song
Z, Liu M, Zeng Q, Cui S and Qu X: CXCL12/CXCR4 axis induced
miR-125b promotes invasion and confers 5-fluorouracil resistance
through enhancing autophagy in colorectal cancer. Sci Rep.
7:422262017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pei G, Lan Y, Chen D, Ji L and Hua ZC: FAK
regulates E-cadherin expression via
p-SrcY416/p-ERK1/2/p-Stat3Y705 and
PPARγ/miR-125b/Stat3 signaling pathway in B16F10 melanoma cells.
Oncotarget. 8:13898–13908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bousquet M, Quelen C, Rosati R, Mansat-De
Mas V, La Starza R, Bastard C, Lippert E, Talmant P,
Lafage-Pochitaloff M, Leroux D, et al: Myeloid cell differentiation
arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid
leukemia with the t(2;11)(p21;q23) translocation. J Exp Med.
205:2499–2506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mizuno Y, Yagi K, Tokuzawa Y,
Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda
A, Amemiya T, et al: miR-125b inhibits osteoblastic differentiation
by down-regulation of cell proliferation. Biochem Biophys Res
Commun. 368:267–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of micro-RNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Visone R, Pallante P, Vecchione A,
Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V,
Borbone E, et al: Specific microRNAs are downregulated in human
thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Yan LX, Wu QN, Du ZM, Chen J,
Liao DZ, Huang MY, Hou JH, Wu QL, Zeng MS, et al: miR-125b is
methylated and functions as a tumor suppressor by regulating the
ETS1 proto-oncogene in human invasive breast cancer. Cancer Res.
71:3552–3562. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gefen N, Binder V, Zaliova M, Linka Y,
Morrow M, Novosel A, Edry L, Hertzberg L, Shomron N, Williams O, et
al: Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1
(TEL/AML1) leukemias and confers survival advantage to growth
inhibitory signals independent of p53. Leukemia. 24:89–96. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang R, Kang Y, Löhr CV, Fischer KA,
Bradford CS, Johnson G, Dashwood WM, Williams DE, Ho E and Dashwood
RH: Reciprocal regulation of BMF and BIRC5 (Survivin) linked to
Eomes overexpression in colorectal cancer. Cancer Lett.
381:341–348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hornsveld M, Tenhagen M, van de Ven RA,
Smits AM, van Triest MH, van Amersfoort M, Kloet DE, Dansen TB,
Burgering BM and Derksen PW: Restraining FOXO3-dependent
transcriptional BMF activation underpins tumour growth and
metastasis of E-cadherin-negative breast cancer. Cell Death Differ.
23:1483–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
